{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:38:14Z","timestamp":1792798694763,"version":"4.5.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AI129636"],"award-info":[{"award-number":["R21 AI129636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 NS106970"],"award-info":[{"award-number":["R21 NS106970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"W.W. Smith Charitable Trust","award":["A17101"],"award-info":[{"award-number":["A17101"]}]},{"name":"AIDS Research","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}]},{"name":"AIDS Research","award":["U01 AI065279"],"award-info":[{"award-number":["U01 AI065279"]}]},{"DOI":"10.13039\/100010633","name":"The Philadelphia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the European Structural and Investments funds for projects \u201cNew generation of highthrougput glycoanalytical services","award":["#KK.01.2.1.01.0003"],"award-info":[{"award-number":["#KK.01.2.1.01.0003"]}]},{"name":"Croatian National Centre of Research Excellence in Personalized Healthcare","award":["#KK.01.1.1.01.0010"],"award-info":[{"award-number":["#KK.01.1.1.01.0010"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Global antibody glycosylation is dynamic and plays critical roles in shaping different immunological outcomes and direct antibody functionality during HIV infection. However, the relevance of global antibody or plasma glycosylation patterns to HIV persistence after antiretroviral therapy (ART) has not been characterized. First, we compared glycomes of total plasma and isolated immunoglobulin G (IgG) from HIV+ ART-suppressed, HIV+ viremic, and HIV-negative individuals. Second, in ART-suppressed individuals, we examined the associations between glycomes and (1) levels of cell-associated HIV DNA and RNA in PBMCs and isolated CD4+ T cells, (2) CD4 count and CD4%, and (3) expression of CD4+ T-cell activation markers. HIV infection is associated with persistent alterations in the IgG glycome including decreased levels of disialylated glycans, which is associated with a lower anti-inflammatory activity, and increased levels of fucosylated glycans, which is associated with lower antibody-dependent cell-mediated cytotoxicity (ADCC). We also show that levels of certain mono- and digalactosylated nonfucosylated glycomic traits (A2G1, A2G2, and A2BG2), which have been reported to be associated with higher ADCC and higher anti-inflammatory activities, exhibit significant negative correlations with levels of cell-associated total HIV DNA and HIV RNA in ART-suppressed individuals. Finally, levels of certain circulating anti-inflammatory glycans are associated with higher levels of CD4 T cells and lower levels of T-cell activation. Our findings represent the first proof-of-concept evidence that glycomic alterations, known to be associated with differential states of inflammation and ADCC activities, are also associated with levels of HIV persistence in the setting of ART suppression.<\/jats:p>","DOI":"10.1002\/jlb.3hi1217-500r","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T06:53:03Z","timestamp":1523343183000},"page":"461-471","source":"Crossref","is-referenced-by-count":46,"title":["Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy"],"prefix":"10.1093","volume":"104","author":[{"given":"Surya Kumari","family":"Vadrevu","sequence":"first","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Trbojevic-Akmacic","sequence":"additional","affiliation":[{"name":"Genos Glycoscience Research Laboratory , Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V","family":"Kossenkov","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Colomb","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila B","family":"Giron","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alitzel","family":"Anzurez","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lynn","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"},{"name":"Department of Medicine, University of Pennsylvania , Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Mounzer","sequence":"additional","affiliation":[{"name":"Jonathan Lax Center, Philadelphia FIGHT , Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L","family":"Landay","sequence":"additional","affiliation":[{"name":"Department of Microbial Pathogens and Immunity, Rush University Medical Center , Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine , Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Papasavvas","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J","family":"Montaner","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Lauc","sequence":"additional","affiliation":[{"name":"Genos Glycoscience Research Laboratory , Zagreb, Croatia"},{"name":"Faculty of Pharmacy and Biochemistry, University of Zagreb , Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Mohsen","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"2023032406112642200_jlb10121-cit-0001","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population","volume":"11","author":"Wandeler","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2023032406112642200_jlb10121-cit-0002","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Instit"},{"key":"2023032406112642200_jlb10121-cit-0003","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0000000000001033","article-title":"Non-AIDS-defining cancer mortality: emerging patterns in the late HAART era","volume":"73","author":"Zucchetto","year":"2016","journal-title":"J Acquir Immune Defici Syndr"},{"key":"2023032406112642200_jlb10121-cit-0004","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e32835cae9c","article-title":"Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population","volume":"27","author":"Rodger","year":"2013","journal-title":"Aids"},{"key":"2023032406112642200_jlb10121-cit-0005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(13)60104-X","article-title":"Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs","volume":"381","author":"Katlama","year":"2013","journal-title":"Lancet"},{"key":"2023032406112642200_jlb10121-cit-0006","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"2023032406112642200_jlb10121-cit-0007","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/QAD.0b013e32834c4ac1","article-title":"Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy","volume":"25","author":"Hunt","year":"2011","journal-title":"Aids"},{"key":"2023032406112642200_jlb10121-cit-0008","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0b013e3182237e54","article-title":"Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection","volume":"57","author":"Lyons","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023032406112642200_jlb10121-cit-0009","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0010","first-page":"61","article-title":"HIV, atherosclerosis and inflammation: implications for treatment","volume":"14","author":"Chan","year":"2009","journal-title":"J HIV Therapy"},{"key":"2023032406112642200_jlb10121-cit-0011","first-page":"118","article-title":"Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy","volume":"17","author":"Deeks","year":"2009","journal-title":"Top HIV Med"},{"key":"2023032406112642200_jlb10121-cit-0012","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev"},{"key":"2023032406112642200_jlb10121-cit-0013","first-page":"50","article-title":"HIV as an inflammatory disease","volume":"14","author":"Smith","year":"2009","journal-title":"J HIV Therapy"},{"key":"2023032406112642200_jlb10121-cit-0014","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0015","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/597476","article-title":"Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection","volume":"199","author":"Jiang","year":"2009","journal-title":"J Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0016","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/587696","article-title":"CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus","volume":"197","author":"Kovacs","year":"2008","journal-title":"J Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0017","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-3083.2008.02184.x","article-title":"Residual viraemia in HIV-1-infected patients with plasma viral load &lt;or = 20 copies\/ml is associated with increased blood levels of soluble immune activation markers","volume":"68","author":"Ostrowski","year":"2008","journal-title":"Scand J Immunol"},{"key":"2023032406112642200_jlb10121-cit-0018","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-8-2","article-title":"Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART","volume":"8","author":"Sedaghat","year":"2008","journal-title":"BMC Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0019","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0198-8859(02)00386-5","article-title":"Differential glycosylation of MHC class II molecules on gastric epithelial cells: implications in local immune responses","volume":"63","author":"Barrera","year":"2002","journal-title":"Hum Immunol"},{"key":"2023032406112642200_jlb10121-cit-0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00280-010-1477-8","article-title":"Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell-cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells","volume":"68","author":"de Freitas","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"2023032406112642200_jlb10121-cit-0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrd708","article-title":"Targeting glycosylation as a therapeutic approach.","volume":"1","author":"Dwek","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2023032406112642200_jlb10121-cit-0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/pr8007539","article-title":"Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns","volume":"8","author":"Meany","year":"2009","journal-title":"J Proteome Res"},{"key":"2023032406112642200_jlb10121-cit-0023","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1021\/pr900092r","article-title":"Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells","volume":"8","author":"Misonou","year":"2009","journal-title":"J Proteome Res"},{"key":"2023032406112642200_jlb10121-cit-0024","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-60761-454-8_14","article-title":"A glycomics approach to the discovery of potential cancer biomarkers","volume":"600","author":"An","year":"2010","journal-title":"Methods Mol Biol"},{"key":"2023032406112642200_jlb10121-cit-0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1155\/2008\/515318","article-title":"Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines","volume":"25","author":"de Leoz","year":"2008","journal-title":"Dis Markers"},{"key":"2023032406112642200_jlb10121-cit-0026","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/clinchem\/46.6.795","article-title":"Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring","volume":"46","author":"Durand","year":"2000","journal-title":"Clin Chem"},{"key":"2023032406112642200_jlb10121-cit-0027","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function.","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023032406112642200_jlb10121-cit-0028","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"key":"2023032406112642200_jlb10121-cit-0029","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10719-006-5409-0","article-title":"Galactosylation of IgG from rheumatoid arthritis (RA) patients\u2013changes during therapy","volume":"23","author":"Pasek","year":"2006","journal-title":"Glycoconjugate J"},{"key":"2023032406112642200_jlb10121-cit-0030","doi-asserted-by":"crossref","first-page":"M111 010090","DOI":"10.1074\/mcp.M111.010090","article-title":"High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations","volume":"10","author":"Pucic","year":"2011","journal-title":"Mol. Cell Proteomics"},{"key":"2023032406112642200_jlb10121-cit-0031","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","article-title":"Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions","volume":"370","author":"Goede","year":"2014","journal-title":"New England J Med"},{"key":"2023032406112642200_jlb10121-cit-0032","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1158\/0008-5472.CAN-09-3704","article-title":"Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer","volume":"70","author":"Junttila","year":"2010","journal-title":"Cancer Res"},{"key":"2023032406112642200_jlb10121-cit-0033","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer.","volume":"12","author":"Scott","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2023032406112642200_jlb10121-cit-0034","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coi.2016.03.005","article-title":"Harnessing Fc receptor biology in the design of therapeutic antibodies","volume":"40","author":"Sondermann","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"2023032406112642200_jlb10121-cit-0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2016.03.002","article-title":"Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies","volume":"73","author":"Thomann","year":"2016","journal-title":"Mol Immunol."},{"key":"2023032406112642200_jlb10121-cit-0036","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1097\/QAD.0000000000000444","article-title":"Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function","volume":"28","author":"Chung","year":"2014","journal-title":"Aids"},{"key":"2023032406112642200_jlb10121-cit-0037","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"2023032406112642200_jlb10121-cit-0038","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"2023032406112642200_jlb10121-cit-0039","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"2023032406112642200_jlb10121-cit-0040","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032406112642200_jlb10121-cit-0041","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0042","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"2023032406112642200_jlb10121-cit-0043","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032406112642200_jlb10121-cit-0044","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.0703354104","article-title":"Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment","volume":"104","author":"Haga","year":"2007","journal-title":"Proc Natl. Acad Sci USA"},{"key":"2023032406112642200_jlb10121-cit-0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaci.2013.09.029","article-title":"Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells","volume":"133","author":"Massoud","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2023032406112642200_jlb10121-cit-0046","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","article-title":"IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes","volume":"116","author":"Seite","year":"2010","journal-title":"Blood"},{"key":"2023032406112642200_jlb10121-cit-0047","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06517.x","article-title":"Multifarious roles of sialic acids in immunity","volume":"1253","author":"Varki","year":"2012","journal-title":"Annal NY Acad Sci"},{"key":"2023032406112642200_jlb10121-cit-0048","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.aids.0000161767.21405.68","article-title":"Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals","volume":"19","author":"Moore","year":"2005","journal-title":"Aids"},{"key":"2023032406112642200_jlb10121-cit-0049","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"2023032406112642200_jlb10121-cit-0051","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0052","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"2023032406112642200_jlb10121-cit-0053","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0054","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.mie.2016.09.027","article-title":"Comparative analysis and validation of different steps in glycomics studies","volume":"586","author":"Trbojevic-Akmacic","year":"2017","journal-title":"Methods Enzymol"},{"key":"2023032406112642200_jlb10121-cit-0055","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1134\/S0006297915070123","article-title":"High-throughput glycomics: optimization of sample preparation. Biochem","volume":"80","author":"Akmacic","year":"2015","journal-title":"Biokhimiia"},{"key":"2023032406112642200_jlb10121-cit-0056","doi-asserted-by":"crossref","first-page":"31234","DOI":"10.1038\/srep31234","article-title":"Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery","volume":"6","author":"Gudelj","year":"2016","journal-title":"Sci Rep"},{"key":"2023032406112642200_jlb10121-cit-0057","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jclinepi.2015.01.001","article-title":"P &lt; 5 \u00d7 10(\u20138) has emerged as a standard of statistical significance for genome-wide association studies","volume":"68","author":"Jannot","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"2023032406112642200_jlb10121-cit-0058","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.38711","article-title":"Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis","volume":"66","author":"Li","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023032406112642200_jlb10121-cit-0059","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.7314\/APJCP.2014.15.3.1125","article-title":"Inflammation, oxidative stress and L-fucose as indispensable participants in schistosomiasis-associated colonic dysplasia","volume":"15","author":"Soliman","year":"2014","journal-title":"Asian Pacific J Cancer Prevent"},{"key":"2023032406112642200_jlb10121-cit-0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/jix225","article-title":"HIV antibody level as a marker of HIV persistence and low-level viral replication","volume":"216","author":"Keating","year":"2017","journal-title":"J Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0061","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/infdis\/jit667","article-title":"HIV antibody characterization as a method to quantify reservoir size during curative interventions","volume":"209","author":"Burbelo","year":"2014","journal-title":"J Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0062","doi-asserted-by":"crossref","first-page":"e1003347","DOI":"10.1371\/journal.ppat.1003347","article-title":"Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient","volume":"9","author":"Yukl","year":"2013","journal-title":"PLoS Pathog"},{"key":"2023032406112642200_jlb10121-cit-0063","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2016.09.038","article-title":"Galectin-3 binds highly galactosylated IgG1 and is crucial for the IgG1 complex mediated inhibition of C5aReceptor induced immune responses","volume":"479","author":"Heyl","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"2023032406112642200_jlb10121-cit-0064","doi-asserted-by":"crossref","first-page":"e1005456","DOI":"10.1371\/journal.ppat.1005456","article-title":"Antigen-specific antibody glycosylation is regulated via vaccination","volume":"12","author":"Mahan","year":"2016","journal-title":"PLoS Pathog"},{"key":"2023032406112642200_jlb10121-cit-0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells","volume":"208","author":"Hatano","year":"2013","journal-title":"J Infect Dis"},{"key":"2023032406112642200_jlb10121-cit-0066","doi-asserted-by":"crossref","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog"},{"key":"2023032406112642200_jlb10121-cit-0067","doi-asserted-by":"crossref","first-page":"e1005761","DOI":"10.1371\/journal.ppat.1005761","article-title":"CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART","volume":"12","author":"Fromentin","year":"2016","journal-title":"PLoS Pathog"},{"key":"2023032406112642200_jlb10121-cit-0068","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/QAD.0000000000000572","article-title":"Select host restriction factors are associated with HIV persistence during antiretroviral therapy","volume":"29","author":"Abdel-Mohsen","year":"2015","journal-title":"AIDS"},{"key":"2023032406112642200_jlb10121-cit-0069","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/pr800737u","article-title":"Variability, heritability and environmental determinants of human plasma N-glycome","volume":"8","author":"Knezevic","year":"2009","journal-title":"J Proteome Res"},{"key":"2023032406112642200_jlb10121-cit-0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/gerona\/glt190","article-title":"Glycans are a novel biomarker of chronological and biological ages","volume":"69","author":"Kristic","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2023032406112642200_jlb10121-cit-0071","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.jprot.2012.02.001","article-title":"Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer","volume":"75","author":"Chen","year":"2012","journal-title":"J Proteomics"},{"key":"2023032406112642200_jlb10121-cit-0072","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0073","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat Med"},{"key":"2023032406112642200_jlb10121-cit-0074","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/fvl-2016-0093","article-title":"HIV-1 latent reservoir: size matters","volume":"11","author":"Hodel","year":"2016","journal-title":"Fut Virol"},{"key":"2023032406112642200_jlb10121-cit-0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","article-title":"Towards an HIV-1 cure: measuring the latent reservoir","volume":"23","author":"Bruner","year":"2015","journal-title":"Trends Microbiol"},{"key":"2023032406112642200_jlb10121-cit-0076","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"2023032406112642200_jlb10121-cit-0077","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"2023032406112642200_jlb10121-cit-0078","doi-asserted-by":"crossref","first-page":"e1003174","DOI":"10.1371\/journal.ppat.1003174","article-title":"Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies","volume":"9","author":"Eriksson","year":"2013","journal-title":"PLoS Pathog"},{"key":"2023032406112642200_jlb10121-cit-0079","doi-asserted-by":"crossref","first-page":"e1003398","DOI":"10.1371\/journal.ppat.1003398","article-title":"Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay","volume":"9","author":"Laird","year":"2013","journal-title":"PLoS Pathog"},{"key":"2023032406112642200_jlb10121-cit-0080","first-page":"343","article-title":"The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption","volume":"30","author":"Li","year":"2016","journal-title":"AIDS"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2FJLB.3HI1217-500R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/104\/3\/461\/49491717\/jlb10121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/104\/3\/461\/49491717\/jlb10121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T06:16:01Z","timestamp":1679638561000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/104\/3\/461\/6935608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,4,6]]},"published-print":{"date-parts":[[2018,8,28]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.3hi1217-500r","relation":{},"ISSN":["1938-3673","0741-5400"],"issn-type":[{"value":"1938-3673","type":"electronic"},{"value":"0741-5400","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,4,6]]}}}